INTRODUCTION
Mucosal-associated invariant T (MAIT) cells are emerging as an important class of T cells with features of both innate and adaptive immunity. The function of MAIT cells is still being elucidated, but a key role is suggested by their conservation across many mammalian species and their high abundance in human blood and mucosal tissues. MAIT cells recognize conserved microbial metabolites generated during riboflavin synthesis, captured by the monomorphic MHC-related protein 1 (MR1). [1] [2] [3] [4] [5] [6] MAIT cells express a conserved ab-T-cell antigen receptor (TCR), consisting of a near-invariant TCRa-chain coupled with a restricted set of b-chains that are relatively conserved in humans and mice. [1] [2] [3] [4] [5] [6] In mice, MAIT TCRs use TRAV1-TRAJ33 (Va19-Ja33) generally assembled with TRBV19 (Vb6) or TRBV13 (Vb8). [7] [8] [9] In humans, most MAIT cells express TRAV1-2-TRAJ33 (Va7.2-Ja33), but TRAV1-2-TRAJ12 or TRAV1-2-TRAJ20 are also used. 8 These TCRa-chains predominantly form receptors with TRBV20 (Vb2) or TRBV6 (Vb13) b-chains, 9 although many other TRBV genes are also used at lower frequency. 8 To date, characterization of MAIT cells in models of infectious diseases has largely depended on analysis of the CD4, CD8 double negative (DN) T-cell population and PCR detection of the Va19Ja33 invariant TCR-a chain as there is no Va19-specific monoclonal antibody (mAb) or the use of Va19Ja33 TCR transgenic. Ca À / À mice. 5, [10] [11] [12] [13] Although Va19 is characteristic of MAIT cells, it is also expressed by non-MAIT T cells. In addition, most conventionally housed inbred mice, with the exception of the wild-derived inbred CAST/EiJ strain, 14 have very low numbers of blood and lymphoid MAIT cells compared with humans, 9 and while TCR transgenic models have been used to help circumvent this problem, 15, 16 the relationship between MAIT cells generated in TCR transgenic vs. wild-type (WT) mice is unclear.
We recently identified by-products of microbial riboflavin synthesis as a major natural source of antigen (Ag) driving MAIT cell activation in vitro. 2, 4, 17 It is unclear whether this pathway is the exclusive source of Ag in vivo, as Vb chain and complementarity determining region 3b (CDR3b) diversity in MAIT TCRs and differential responses to diverse pathogens might reflect diversity in MAIT Ags. [18] [19] [20] Indeed, a number of MAIT cell Ags were identified, including 5-(2-oxopropylideneamino)-6-D-ribitylaminouracil (5-OP-RU), 5-(2-oxoethylideneamino)-6-D-ribitylaminouracil (5-OE-RU), 6,7-dimethyl-8-D-ribityllumazine (RL-6,7-diMe), and 7-hydroxy-6-methyl-8-D-ribityllumazine (RL-6-Me-7-OH), which vary considerably in potency, as well as non-stimulatory MR1 ligands, including 6-formyl-pterin (6-FP), a natural breakdown product of folic acid.
2,4 5-OP-RU and 5-OE-RU, the most potent MAIT cell Ags, are created from the riboflavin precursor 5-amino-6-D-ribitylaminouracil (5-A-RU) by non-enzymatic condensation with small ubiquitous metabolites methylglyoxal and glyoxal, respectively. 2 This finding has enabled the production of highly specific MR1-Ag tetramers that stain all MAIT cells in mice and humans. 2 Here we have examined the behavior, functionality, and phenotype of mouse MAIT cells, detected using MR1-5-OP-RU tetramers, in a bacterial lung infection model in C57BL/6 mice. Our data reveal that MAIT cell activation and accumulation in vivo was dependent on the presence of a functional riboflavin synthesis pathway in the microbial pathogen and expression of MR1 in the host mice. The cell-surface phenotype and functional properties of MAIT cells indicate a responsiveness of MAIT cells to infection. These studies have substantially advanced our understanding of the functional capacity of MAIT cells in vivo.
RESULTS

MAIT cells accumulate in the lungs of mice following infection with Salmonella Typhimurium
Using Salmonella enterica serovar Typhimurium (S. Typhimurium), we previously showed that the ability to stimulate MAIT cells in vitro depends on the presence of an intact microbial riboflavin pathway, specifically involving genes necessary for the production of riboflavin precursor compounds, 4 including 5-A-RU. 2 We showed how 5-A-RU recombines with small metabolites to form MAIT-activating ligands, including the most potent identified to date, 5-OP-RU. 2 Tetramers of human or mouse MR1 loaded with 5-OP-RU specifically detect MAIT cells in the respective species. 2, 8, 21, 22 Mouse MR1-5-OP-RU tetramers were used here to identify MAIT cells (defined as TCRb þ MR1-5-OP-RU tetramer þ cells) in single-cell suspensions derived from the lungs, reproductive tract, liver, spleen, thymus, blood, and mesenteric lymph nodes (LNs) of uninfected C57BL/6 mice. MAIT cells represented B2% of ab-T cells in the reproductive tract, and about 0.5-2% of ab-T cells in the lung, with lower proportions in blood and other organs (Figure 1a) , consistent with recent findings. 21 In contrast, we could not detect MAIT cells from C57BL/6.MR1
À / À mice ( Figure 1a,b) , confirming earlier findings that MR1 is vital for MAIT cell development. 6, 16 We next examined the impact of lung infection on MAIT cells in a model involving inoculation of mice with liveattenuated vaccine strain S. Typhimurium BRD509. 23, 24 Although S. Typhimurium is not a natural pathogen in the lung, it is known to activate MAIT cells in vitro and genetic manipulation of this bacterium now allows us to probe the Ag requirements for MAIT cell activation in vivo. Following intranasal (i.n.) infection with S. Typhimurium BRD509, there was a substantial enrichment of MAIT cells in the lungs of C57BL/6 mice such that they comprised 25-50% of all infiltrating lung ab-T cells after 1 week (Figure 1b Figure S1 ). Thus the MAIT cell accumulation and enrichment in this model was MR1 dependent. The accumulation of lung MAIT cells was also dependent on the size of the bacterial inoculum ( Figure 1d ) and peaked at day 7 postinfection (d7 p.i.) (Figure 1e ).
In vivo enrichment of MAIT cells p.i. requires Ag derived from a bacterial riboflavin pathway
To confirm the requirement for microbial riboflavin metabolites in driving the in vivo MAIT cell response, we constructed a mutant strain of BRD509 in which ribD and ribH genes, which are co-located in the Salmonella genome, were deleted: BRD509DribDH. Although deficiency of the ribH gene does not impact on bacterial activation of MAIT cells, 2 the ribD gene is essential for production of the 5-A-RU precursor to MAIT cell Ags 5-OP-RU and 5-OE-RU. 2 The mutant BRD509DribDH bacteria were first tested in vitro, and bacterial supernatants were found to be deficient in their ability to stimulate reporter cells expressing a MAIT TCR (Jurkat.-MAIT) 4 in an MR1-dependent activation assay (Figure 2a) . By comparison, BRD509 supernatant (WT) caused upregulation of CD69 on Jurkat.MAIT reporter cells (Figure 2a) . Supernatant from the BRD509DribDH bacteria reconstituted with ribD and ribH genes (BRD509DribDH þ ribDH) activated Jurkat. MAIT cells to WT levels (Figure 2a) , confirming previous in vitro results obtained with mutants of another Salmonella strain. 2 In contrast to S. Typhimurium BRD509, infection with BRD509DribDH bacteria did not evoke MAIT cell accumulation beyond the resident MAIT cell numbers in the uninfected lungs (Figure 2b,c) . This lack of MAIT cell accumulation was unlikely the result of the reduced growth rate of BRD509DribDH as a 10-fold higher dose of BRD509DribDH bacteria was used, resulting in equivalent bacterial counts at day 7 (see Supplementary Figure S2 ), and non-MAIT ab-T cells still accumulated (Figure 2b) . Moreover, the non-responsiveness of MAIT cells to infection with BRD509DribDH Salmonella could be rescued if the bacteria were co-administered i.n. with synthetic MAIT cell Ag 5-OP-RU delivered i.n. (Figure 2b macrophage-activating lipopeptide-2 (MALP-2) and has been shown to be an agonist for TLR2. 27, 28 Poly I:C is a TLR3 agonist similar to double-stranded RNA. 29 CpG oligonucleotides stimulate through TLR9. 30 Challenge with each TLR agonist by itself, or with the non-activating MR1 ligand 6-FP, led to a lesser (2-3-fold) enrichment for MAIT cells in the lungs, suggesting that co-stimuli alone can exert some influence on MAIT cells (Figure 2d ). In addition, although i.n. challenge with Ag alone did not induce accumulation of lung MAIT cells, it did induce rapid upregulation of CD69 on MAIT cells in vivo as early as 2 h following inoculation (Figure 2e) . However, the i.n. co-administration of synthetic Ag 5-OP-RU and Pam2Cys, poly I:C, or CpG led to a 15-25-fold enrichment of MAIT cells in the lung in the absence of any bacterial challenge (Figure 2d,f) . At least for Pam2Cys plus 5-OP-RU, this response was sustained over time (not shown) and was largely blocked by administration of anti-MR1 mAb (see Supplementary Figure S1b ). Thus the failure of i.n. 5-OP-RU alone to drive MAIT cell enrichment was not necessarily the result of the lability of the Ag, suggesting that MAIT cell accumulation and enrichment require stronger signals than those needed for activation. Indeed, repeated (6 Â ) i.n. administration of 5-OP-RU alone over a 7-day period was still an insufficient stimulus to induce MAIT cell accumulation, despite sustained Ag exposure (Figure 2f ). Taken together, these findings demonstrate that rib-defective (and thus MAIT cell Ag deficient) bacteria and TLR agonists are independently capable of providing a co-stimulus that helps to drive MAIT cell accumulation and enrichment in response to 5-OP-RU Ag in vivo (Figure 2c,d ).
Infection induces interleukin (IL)-17 production, an increase in T-bet expression, and the long-lived retention of phenotypically effector/memory MAIT cells in situ Upon activation in vitro, MAIT cells produce interferon-g (IFNg), tumor necrosis factor (TNF), and IL-17. 4, 8, 13, 31 This pattern of cytokine expression was mirrored following i.n. inoculation with S. Typhimurium ( Figure 3 , see Supplementary Figures S5 and S6 ). Most striking was the production of IL-17, which was detected in approximately 30% of lung MAIT cells directly ex vivo at d7 without further stimulation ( Figure 3) . Interestingly, MAIT cells still appeared 'primed' to rapidly secrete IL-17 long-term p.i. (Figure 3) , suggesting that MAIT cells acquire rapid responsiveness as they differentiate into their memory phase. In contrast, a higher proportion of non-MAIT ab-T cells than MAIT cells produced IFNg and TNF 7 days p.i. (Figure 3 , see Supplementary Figure S4) .
The transcriptional factor promyelocytic leukemia zinc finger (PLZF) is a master regulator of innate-like T-cell development, including natural killer T cells and some gdT cells. 32 Both human and mouse MAIT cells express PLZF.
16,21
Notably, we found that PLZF was expressed by nearly all lung MAIT cells both before and after infection, along with the orphan nuclear receptor, retinoic acid-related orphan receptor gt (RORgt), which has a key role in differentiation of T helper type 17 (Th17) cells 33 and is expressed by human and mouse MAIT cells 21, 31 ( Figure 4a , see Supplementary Figure S5 ). In addition, we examined the expression of the transcription factor T-bet, a key regulator of Th1 type immunity. 34 T-bet is reported to suppress IL-17 expression and promote Th1 development, whereas loss of T-bet expression can induce commitment to Th2 and loss of IFNg expression. [35] [36] [37] The expression of RORgt declined slightly in MAIT cells as T-bet expression levels increased from d7 to d142 p.i. Interestingly, the majority of cells long-term p.i. co-expressed the two transcription factors (Figure 4b , see Supplementary Figure  S5 ). The production of IL-17 by MAIT cells d7 p.i. either directly ex vivo or following phorbol myristate acetate (PMA) stimulation, was observed in the presence of either T-bet or RORgt (or both) (Figure 4c , see Supplementary Figure S6 ). In contrast, at the same time point, a much smaller proportion of MAIT cells produced IFNg after PMA stimulation and most of these expressed T-bet. This pattern was also true for IFNg production by non-MAIT cells (Figure 4c ). IL-17 and IFNg appeared to be independently expressed by MAIT cells, as shown by co-staining (see Supplementary Figure S7) .
Even before infection, CD44, a cell adhesion molecule highly expressed on memory T cells, was expressed by most MAIT cells. In contrast, a smaller proportion of non-MAIT ab-T cells expressed CD44 preinfection and p.i. (Figure 5 ). CD62L (L-selectin) is highly expressed on naive T cells and is used to further distinguish central memory (CD62L þ ) from effector memory (CD62L À ). The regulation of CD62L has a pivotal role in controlling the traffic of conventional T lymphocytes through peripheral LNs, with CD62L shed from the cell membrane following activation. 38 Not surprisingly, CD62L remained low on lung MAIT cells at all three phases: homeostatic MAIT cells in the absence of infection, activated MAIT cells (during infection), and Ag experienced MAIT cells (4d30 p.i.) ( Figure 5 ). These observations are consistent with the effector/memory phenotype previously described for human MAIT cells. 31 However, the proportion of MAIT cells expressing the activation marker CD69 increased from B20% preinfection to 90% p.i. (Figure 5b) , consistent with our other results showing that further activation of MAIT cells occurred following infection. MAIT cells from the lungs of uninfected mice also showed CD25 expression (not shown).
One possibility is that the enrichment of MAIT cells in the lungs is due to recruitment from blood and other sites. To evaluate this possibility, we examined MAIT cell enrichment in lungs and draining LNs vs. possible loss in other organs over 7 weeks following infection with BRD509 (Figure 6a,b) . 1, 12 The enrichment of MAIT cells as a proportion of all ab-T cells was most evident in the lungs of infected mice (d7, 35-50% of ab-T cells) but was only evident in the draining LNs and spleen at week 7 (Figure 6a,b) , suggesting redistribution to these sites during the resolution phase of the infection (Figure 6c) . No MAIT cell loss was observed in the spleen or draining LNs, where the percentage of MAIT cells remained stable throughout the infection course and increased slightly during the late course (Figure 6a,b) .
Together, our data show a rapid MAIT cell response to bacterial lung infection, which was dependent on MR1 presentation of riboflavin biosynthesis-derived ligands. MAIT cell accumulation and proliferation, but not CD69 upregulation, was dependent on second signals, which could be furnished through TLR ligation or by bacteria. Cell surface markers and cytokine production were consistent with an effector/memory phenotype.
DISCUSSION
We have developed a model bacterial infection in mice to evaluate the importance of the riboflavin synthesis pathway in driving MAIT cell responses in vivo and to define the phenotypic and functional characteristics of the responding MAIT cells. The generation of highly specific MR1-Ag tetramers 2, 8 has allowed the precise Ag-dependent definition of MAIT cells, which are much less abundant in WT mice than humans, 9 overcoming potential confusion engendered by using surrogate markers of MAIT cells or transgenic mice. Using MR1-Ag tetramers, we show that MAIT cells are readily detectable, albeit in low numbers, in WT C57BL/6 mice, being most abundant in the reproductive tract, lung, and liver. We exploited the capacity of S. Typhimurium, which we previously showed to potently activate MAIT cells in vitro 2, 4 as a model to analyze MAIT cell responses and activation requirements in vivo, with the respiratory tract providing an accessible organ to assess MAIT activation. S. Typhimurium is a gastrointestinal pathogen of humans and a systemic pathogen of mice. Clearance of S. Typhimurium in mice is achieved through a number of redundant cellular mechanisms, including CD4 þ , and to a lesser extent CD8 þ , T cells. 23 In our respiratory model, lung clearance was independent of the presence of MAIT cells, suggesting their redundancy as protective T cells in this model too. It would be interesting to establish whether the type or kinetics of the non-MAIT immune response differed in the absence of MAIT cells. Nevertheless, i.n. infection of mice led to a substantial increase in MAIT cells in the lung to up to 50% of all pulmonary ab-T cells (a B200-fold increase in absolute numbers vs. B5-fold for non-MAIT cells). This enrichment peaked at d7 and was MR1 dependent, as shown genetically (in MR1 À / À mice) and by anti-MR1 mAb blocking, consistent with previous in vitro data. [1] [2] [3] [4] [5] [6] The accumulation of MAIT cells was directly related to the size of the bacterial inoculum. Interestingly, expanded MAIT cells were long lived in the lung and other tissues, persisting in higher numbers than found in uninfected mice long after S. Typhimurium was cleared to undetectable levels (B10 weeks). It is interesting to speculate that a history of infection in humans could explain the higher proportion of MAIT cells compared with specific pathogenfree-housed mice, and it will be exciting to discover the role of MAIT cells in immune protection against a range of microbial respiratory pathogens.
Genetic manipulation of S. Typhimurium allowed us to demonstrate that responsiveness of MAIT cells in vivo required an intact riboflavin pathway and hence was abolished upon disruption of the key ribD gene responsible for generating the precursor 5-A-RU, which generates the dominant MAIT cell ligand, 5-OP-RU. Notably, the BRD509DribDH mutant could still induce weak, transient upregulation of MAIT MAIT cells in vivo. It remains unclear whether there are natural MAIT cell Ags derived from pathways other than riboflavin synthesis. The variability of MAIT TCRs from the semiinvariant MAIT TCR combinations 7, 8, 18 suggests that these receptors may be selected by alternate ligands and MAIT cells have an apparent capacity o discriminate between pathogenderived ligands in a clonotype-dependent manner. 20 On the other hand, the semi-invariant a and restricted b chain usage, the importance of the conserved Tyr 95a residue across the TRAJ33, TRAJ20 and TRAJ12 gene segments tested to date, and the stereotypic mode of binding of the MAIT TCR to all known ligands and analogues studied 1, 2, 4, [17] [18] suggest that a limited ligand family is recognized by MAIT cells. Accordingly, the abrogation of MAIT cell accumulation and activation following mutagenesis of the riboflavin synthesis pathway implies that this pathway furnishes the dominant, and likely exclusive, family of natural Ags recognized by MAIT cells at least for S. and control of Francisella tularensis intracellular growth required the IL-12 40-kDa subunit, implying a need for additional signals from infected Ag-presenting cells (APCs). 13 These observations are consistent with our finding that a co-stimulus was required to induce MAIT cell accumulation in the lungs following i.n. administration of synthetic MAIT cell Ag, 5-OP-RU, even when delivered repeatedly over 7 days, and despite inducing MAIT cell upregulation of CD69. In contrast, i.n. administration of 5-OP-RU plus the TLR agonists Pam2Cys (TLR2/6), poly I:C (TLR3), or CpG (TR9) induced enrichment of lung MAIT cells to the approximate level achieved by S. Typhimurium infection. Importantly, addition of 5-OP-RU during i.n. challenge with bacteria lacking the riboflavin synthesis pathway (BRD509DribDH mutant) restored their capacity to induce MAIT cell accumulation in the lungs, indicating that co-stimulatory capacity is inherent in bacterial infection and has a role in the expansion and responsiveness of MAIT cells.
The phenotype of MAIT cells that expand in response to infection with S. Typhimurium is consistent with previous studies of in vitro-stimulated MAIT cells, in that they express activation markers even before infection and produce proinflammatory cytokines IL-17, IFNg, and TNF upon activation by microbes. This is also consistent with a study of pulmonary infection of mice with F. tularensis, 13 although, of note, this study defined MAIT cells as DN thus not addressing a potential role for CD8 þ or CD4 þ MAIT cells in response to infection. The expression of CD69 on 20% of MAIT cells, compared with B4% of non-MAIT cells, in the steady state is intriguing and could suggest that there may be stimulation of MAIT cells through the presence of commensal microbes providing Ag at mucosal sites. As well as being described as an early-activation marker, CD69 expression has been previously shown on human tissue resident memory T cells 41 and to have a role in tissue retention of T cells. 42 However, further stimulation of MAIT cells, and CD69 upregulation, could be induced by infection or provision of Ag plus co-stimulatory signals. The expansion of MAIT cells following infection may be a consequence of the lower number of MAIT cells in mice vs. humans. Interestingly, once expanded, the MAIT cells are long lived in primary tissues, preserving their activation and homing phenotype and maintaining expression of their transcriptional signature PLZF and RORgt but with gradual increase in the level of T-bet, known to co-ordinate developmental and effector programs some of which are conserved across adaptive and innate T cells.
Our study presents a picture of MAIT cell responsiveness to pathogens that bridges attributes of innate and adaptive immunity but that is dependent on specific Ag expressed by the infecting pathogen. 43 It will be fascinating to unravel whether these cells have evolved in response to a range of pathogens with shared Ag(s) or whether they have a more focused role, perhaps involving a single pathogen family possibly at a key site. Compounds and immunogens. 5-OP-RU was prepared as described previously. 2 6-FP was purchased from Schircks Laboratories (Jona, Switzerland). TLR2/6 agonist Pam2Cys 44 were chemically synthesized and functionally verified. CpG1688 (Sequence: T*C*C*A*T*G*A*C* G*T*T*C*C*T*G*A*T*G*C*T (*phosphorothioate linkage) nonmethylated cytosine-guanosine oligonucleotides was purchased from Geneworks (Thebarton, Australia). Poly (I:C) (HMW VacciGrade) was purchased from InvivoGen (San Diego, CA).
Bacterial strains and mutants. S. Typhimurium BRD509, (previously described 45, 46 ) harbors deletions in aroA and aroD, resulting in limitation of replication of bacteria 24, 45 and has an intact riboflavin synthesis pathway. The BRD509DribDH mutant, lacking a gene segment containing ribD and ribH, which encode key enzymes in the riboflavin synthesis pathway, was constructed by lamda redrecombinase-mediated allelic replacement followed by transduction using phage P22 as previously described. 24 BRD509DribDH cultures were supplemented with 20 mg ml À 1 riboflavin. BRD509DribDH complemented by transformation of ribDH genes resulted in strain BRD509DribDH þ ribDH. Mutation and reconstitution were verified by lack of growth or growth on Luria Agar and by PCR. Bacteria were cultured at 37 1C statically, in Luria Bertani broth with appropriate antibiotics for 16-18 h to log-phase (OD 600 0.6-0.9). Supernatant was collected by centrifugation, filtered (0.22 mm) and stored at À 80 o C until use. For the infecting inoculum, bacteria were re-inoculated in prewarmed medium for a further 2-4 h static culture (OD 600 0.4-0.6). With the estimation that 1 OD 600 ¼ 5 Â 10 8 ml À 1 , sufficient bacteria were washed and diluted in phosphatebuffered saline (PBS) for i.n. delivery to mice. A sample of inoculum was plated onto Luria Agar with appropriate antibiotics for verification of bacterial concentration by counting colony-forming units.
Mice and inoculations. Mice were bred and housed in the Biological Research Facility of the Peter Doherty Institute (Melbourne, Victoria, Australia). MR1
À / À mice were generated by breeding Va19iCa À / À MR1 À / À mice 15 (from Susan Gilfillan, Washington University, St Louis School of Medicine, St Louis, MO) with C57BL/6 mice and inter-crossing of F1 mice. The genotype was determined by tail DNA PCR at the MR1 locus and by the presence of intact ab-T cells in blood using Ab against TCRb. The absence of MAIT cells was verified by flow cytometry in the retired founder breeder mice. Male mice aged 6-12 weeks were used in experiments, after approval by the University of Melbourne Animal Ethics Committee.
I.n. inoculation with S. Typhimurium (BRD509: 10 6 or BRD509DribDH: 10 7 unless otherwise stated) or Ags (76 pmol 5-OP-RU or 6-FP alone or plus 20 nmol Pam2Cys, 20 mg CpG, or 50 mg poly I:C) in 50 ml per nares was performed on anesthetized mice. For blocking experiments, mice were given 250 mg anti-MR1 (26.5 or 8F2.F9) 25, 26 or isotype control mAbs in 200 ml PBS, once (i.v or intraperitoneally) 1 day prior to inoculation and three times (d1, d3, d5) postinoculation. Mice were killed by administration of CO 2 and organs: lung (following heart perfusion with 10 ml cold RPMI), liver (following portal vein perfusion with 10 ml RPMI), mediastinal LNs, blood, spleen, thymus, vagina, and uterus were taken.
Preparation of organs and isolation of cells. To prepare single-cell suspensions, lungs, uterus, and vagina (pooled from three mice) were finely chopped with a scalpel blade and treated with 3 mg ml À 1 collagenase III (Worthington, Lakewood, NJ), 5 mg ml À 1 DNAse, and 2% fetal calf serum in RPMI for 90 min at 37 1C with gentle shaking. Cells were then filtered (70 mm) and washed with PBS/2% fetal calf serum. Liver lymphocytes were prepared by pushing through metal mesh, followed by Percoll (33.75%) density gradient centrifugation (693 g, 12 min, room temperature). LNs, spleen, and thymus were prepared by pushing the tissues through 70-mm cell strainers. Red blood cells were lysed from lung, liver, and spleen preparations with hypotonic buffer TAC (Tris-based amino chloride) for 5 min at 37 1C. Approximately 1.5 Â 10 6 cells were filtered (40 mm) and used for flow cytometric analysis. Blood cells were prepared by centrifugation and serum removal. Red blood cell lysis was by Lysing buffer (BD Biosciences, North Ryde, NSW, Australia) after flow cytometric staining.
Determination of bacterial counts in infected lungs. Bacterial colonization was determined by counting colony-forming units obtained from plating homogenized organs from infected mice (X5 per group) on Luria agar containing appropriate antibiotics and supplements.
Generation of soluble MR1 tetramers. Murine MR1 and b2-Microglobulin genes were expressed in Escherichia coli inclusion bodies, refolded, and purified as described previously.
17 MR1-5-OP-RU and MR1-6-FP tetramers were generated as described previously. 2 Abs and flow cytometry. Ab against CD19 (1D3, PerCP-Cy 5.5), CD3 (UCHT1, PE or 145-2C11, PE-Cy7), CD4 (GK1.5, APC-Cy7), CD45.2 (104, FITC), CD69 (FN50, APC), IFNg (XMG1.2, PE-Cy7), TCRb (H57-597, APC or FITC), CD44 (IM7, PE), TNF (MP6-XT22, PE), and IL-17A (TC11-18H10, AlexaFluor700) were purchased from BD (Franklin Lakes, NJ). Ab against MHC II (M5, AlexaFluor700), CD69 (H1.2F3, PE), CD25 (PC61.5, APC), PLZF (Mags.21F7, PE), RORgt (B2D, APC), and T-bet (4B10, PE-Cy7) were purchased from eBioscience (San Diego, CA). Ab against CD62L (Mel-14, FITC) was purchased from Biolegend (San Diego, CA). Blocking Ab (26.5, 8F2.F9) and isotype controls (3E12, 8A5) were prepared in house. To block non-specific staining, cells were incubated with MR1-6FP tetramer and anti-Fc receptor (2.4G2) for 15 min at room temperature and then incubated at room temperature with Ab/tetramer cocktails in PBS/2% fetal calf serum. 7-aminoactinomycin D (5 ml per sample) was added for the last 10 min. Cells were fixed with 1% paraformaldehyde prior to analysis on LSRII or LSR Fortessa (BD Biosciences) flow cytometers. Data analysis was performed with the FlowJo software (Ashland, OR). For intracellular cytokine staining, Golgi plug (BD Biosciences) was used during all processing steps. Cells stimulated with PMA/ionomycin (20 ng ml À 1 , 1 mg ml À 1 , respectively) for 3 h at 37 1C were included as positive controls. Surface staining was performed at 37 1C, and cells were stained for intracellular cytokines using the BD Fixation/Permeabilization Kit (BD, Franklin Lakes, NJ) or transcription factors using the transcription buffer staining set (eBioscience) according to the manufacturers' instructions.
Statistical analysis. Statistical tests were performed using the Prism GraphPad software (version 6, La Jolla, CA). Comparisons between groups were performed using Student's t-test, unless otherwise stated.
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